05 Mar, 2021 08:21 AM
Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to report it has decided to expand Part B of...read more
01 Mar, 2021 08:20 AM
In accordance with ASX Listing Rule 3.14, Acorn Capital Investment Fund Limited (ASX: ACQ) wishes to advise that as of immediate effect its registered office and principle place of business will cha...read more
26 Feb, 2021 04:21 PM
Xplore Wealth Limited (ASX: XPL) (the Company) releases its Appendix 4D (Half Year Report) and Interim Report for the half year ended 31 December 2020, as approved by the Board.
For more informat...read more
26 Feb, 2021 08:46 AM
SUDA Pharmaceuticals Ltd (ASX: SUD), a leader in oro-mucosal drug delivery, advises that SUDA has contracted the services of MedPharm, who will perform formulation development work to assist in stab...read more
25 Feb, 2021 12:29 PM
Cyclopharm Limited (ASX: CYC) is pleased to provide the following update on its business and financial performance for FY2020, including progress towards gaining United States Food and Drug Administ...read more